Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening.
Autor: | Faizan S; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Constituent College of JSS Academy of Higher Education & Research Mysuru 570015 India brprashanthkumar@jssuni.edu.in +91-821-2548359 +91-821-2548353., Talath S; Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University Ras Al Khaimah UAE., Wali AF; Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University Ras Al Khaimah UAE., Hani U; Department of Pharmaceutics, College of Pharmacy, King Khalid University Abha Saudi Arabia., Haider N; Department of Pathology, College of Medicine, King Khalid University Abha Saudi Arabia., Mandal SP; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Constituent College of JSS Academy of Higher Education & Research Mysuru 570015 India brprashanthkumar@jssuni.edu.in +91-821-2548359 +91-821-2548353., Kumar BRP; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Constituent College of JSS Academy of Higher Education & Research Mysuru 570015 India brprashanthkumar@jssuni.edu.in +91-821-2548359 +91-821-2548353. |
---|---|
Jazyk: | angličtina |
Zdroj: | RSC advances [RSC Adv] 2024 Apr 09; Vol. 14 (16), pp. 11368-11387. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024). |
DOI: | 10.1039/d4ra01424c |
Abstrakt: | A series of novel symmetrical and asymmetrical dihydropyridines (HD 1-15) were designed, subjected to in silico ADMET prediction, synthesized, analyzed by IR, NMR, Mass analytical techniques and evaluated against epidermal growth factor receptor (EGFR) as inhibitors against Breast cancer. The results of predicted ADMET studies demonstrated the drug-likeness properties of the reported compounds. The in vitro cytotoxicity assessment of the synthesized compounds revealed that all of them showed good activity (IC Competing Interests: The authors declare no financial conflicts of interest or personal affiliations that could have influenced the research conducted in this study. (This journal is © The Royal Society of Chemistry.) |
Databáze: | MEDLINE |
Externí odkaz: |